Standout Papers
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis (2008)
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis (2012)
- Multiple sclerosis (2018)
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial (2011)
- Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis (2007)
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells (2012)
- Serologic diagnosis of NMO (2012)
- Bruton tyrosine kinase inhibitors for multiple sclerosis (2023)
Immediate Impact
8 by Nobel laureates 9 from Science/Nature 112 standout
Citing Papers
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
Works of Amit Bar‐Or being referenced
P2Y12 expression and function in alternatively activated human microglia
2015
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
2012 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Amit Bar‐Or | 14073 | 8979 | 5667 | 447 | 25.1k | |
| Moses Rodriguez | 13425 | 6470 | 6045 | 483 | 26.6k | |
| Tomas Olsson | 14064 | 10436 | 5458 | 673 | 30.4k | |
| Ralf Gold | 10119 | 6990 | 7925 | 770 | 27.5k | |
| Reinhard Hohlfeld | 9967 | 7576 | 5967 | 299 | 22.8k | |
| Wolfgang Brück | 14391 | 7025 | 6731 | 390 | 31.5k | |
| Henry F. McFarland | 15024 | 9933 | 4741 | 260 | 26.6k | |
| Gavin Giovannoni | 13537 | 4102 | 6959 | 667 | 25.2k | |
| Krzysztof Selmaj | 9341 | 5341 | 3530 | 334 | 17.3k | |
| Bernhard Hemmer | 9250 | 6814 | 4323 | 350 | 19.5k | |
| Eva Havrdová | 18266 | 4351 | 6056 | 376 | 22.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...